Drug & Supplement Interactions

K2/Spice + Nylidrin

Brand name of Nylidrin

  • Arlidin

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated October 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Best Avoided

We found no known interaction between K2/Spice and Nylidrin in our sources, but our pharmacy team rates K2/Spice itself best avoided. These products are illegal, unregulated, and have caused serious harm and death.

This also applies to Arlidin, a brand name of nylidrin.

See the Full Interaction Report

Ask a Question About This Combination

Ask in your own words about taking K2/Spice with Nylidrin. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

K2/Spice and Nylidrin Interaction Check

No Known Interaction, but K2/Spice Is Best Avoided

We did not find a documented interaction between Nylidrin and K2/Spice in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Our pharmacy team rates K2/Spice best avoided, whatever else you take. These products are illegal, unregulated, and have caused serious harm and death. See K2/Spice’s safety ratings →

How We Checked

Why No Interaction Is Listed for Nylidrin

We sort drugs into categories, such as blood thinners or antibiotics, and many supplement interactions are recorded for a whole category rather than for one drug. So we checked every category Nylidrin is in against every category K2/Spice has a known interaction with.

2Categories Nylidrin Is In
  • Vasodilators No K2/Spice Record
  • Oral Drugs Any drug taken by mouth. No K2/Spice Record
2Drug Categories K2/Spice Interacts With

No overlap. Nylidrin is in none of the 2 categories K2/Spice interacts with, so no record links the two.

Still wondering about combining K2/Spice and Nylidrin? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
Know someone taking this combination? Share
What to Watch For

What K2/Spice Itself Has Been Linked To

  • This is not an interaction: nothing below involves Nylidrin.
  • It is the side-effect record for K2/Spice on its own, from the licensed Natural Medicines monograph.
  • If something new turns up after you add K2/Spice, this list is the first place to look.
  • 8 entries are worth acting on rather than waiting out, marked below.
  • Dependence or withdrawal symptoms / Thoughts of self-harm Worth Acting On Additional detail

    When inhaled, K2/spice can cause agitation, psychosis, delirium, hallucinations, paranoia, anxiety, confusion, altered mental status, panic attacks, aggressive behaviors, and suicidality. Agitation, which escalates to delirium and psychosis, appears to be the most common acute psychiatric adverse effect reported after K2/spice use, occurring in up to 41% of toxicity cases.

    Source: , the clinical database we license.

    6 references cited
    1. 98847. Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E, Molina-Holgado F. Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events. Adv Pharmacol 2017;80:135-68. PubMed
    2. 98848. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: a case report. Clin Schizophr Relat Psychoses 2015;8(4):205-8. DOI
    3. 99616. Lamy FR, Daniulaityte R, Nahhas RW, et al. Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. Int J Drug Policy. 2017;44:121-9. PubMed
    4. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
    5. 99618. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12-41. PubMed
    6. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed
  • Severe muscle breakdown Worth Acting On Additional detail

    When inhaled, K2/spice has been associated with rhabdomyolysis. In one case series, 8 of 30 patients requiring critical care for K2/spice use experienced rhabdomyolysis. Also, a 23-year-old male who smoked K2/spice daily for two weeks presented to the emergency department with psychosis, severe agitation, and highly elevated creatine phosphokinase (CPK) levels.

    Source: , the clinical database we license.

    2 references cited
    1. 98848. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: a case report. Clin Schizophr Relat Psychoses 2015;8(4):205-8. DOI
    2. 103080. Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. JAMA Netw Open. 2020;3(7):e208516. PubMed
  • Memory problems Worth Acting On Additional detail

    When inhaled, K2/spice can cause drowsiness, lethargy, vertigo, ataxia, hyperreflexia, nystagmus, confusion, anxiety, cognitive impairment, emotional dysregulation, seizures, and coma. Numerous cases of seizures secondary to K2/spice use have been reported.

    Source: , the clinical database we license.

    6 references cited
    1. 99616. Lamy FR, Daniulaityte R, Nahhas RW, et al. Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. Int J Drug Policy. 2017;44:121-9. PubMed
    2. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
    3. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed
    4. 99621. Schwartz MD, Trecki J, Edison LA, Steck AR, Arnold JK, Gerona RR. A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. J Emerg Med 2015;48(5):573-80. PubMed
    5. 99624. Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 2016;54(1):1-13. PubMed
    6. 103080. Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. JAMA Netw Open. 2020;3(7):e208516. PubMed
  • Unsteadiness Worth Acting On Additional detail

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Severe muscle breakdown above.

  • A heart attack / High blood sugar Worth Acting On Additional detail

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Severe muscle breakdown above.

  • A slow heartbeat Worth Acting On Additional detail

    When inhaled, K2/spice can cause serious adverse cardiovascular effects, including tachycardia or bradycardia, hypertension or hypotension, coronary vasospasm, acute coronary syndrome, congestive heart failure, ventricular fibrillation, QT prolongation, myocardial ischemia/infarction, stroke, cardiac arrest, cardiomyopathy, and sudden cardiac death.

    Source: , the clinical database we license.

    6 references cited
    1. 98843. Andonian DO, Seaman SR, Josephson EB. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - a case series. Am J Emerg Med 2017;35(6):940.e5-940.e6. PubMed
    2. 98844. McIlroy G, Ford L, Khan JM. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report. BMC Pharmacol Toxicol 2016;17:2. PubMed
    3. 98846. Clark BC, Georgekutty J, Berul CI. Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr 2015;167(3):757-61.e1. PubMed
    4. 98849. Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana "spice". Neurology 2013;81(24):2090-3. PubMed
    5. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
    6. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed
  • Hallucinations Worth Acting On Additional detail

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under Severe muscle breakdown above.

  • Heart failure Worth Acting On Additional detail

    Recorded for K2/Spice in the same Natural Medicines adverse-effect record shown under A slow heartbeat above.

Showing the 10 most notable of 34 recorded effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

Everything above comes from the Natural Medicines adverse-effect record for K2/Spice — expand a row for the licensed statement it rests on. We haven’t matched Nylidrin to its FDA label in our system yet, so we can’t compare its own side-effect list here — the leaflet that comes with your prescription is the authoritative list for Nylidrin.

If You Already Take Both
  • Tell your pharmacist or doctor that you take K2/Spice, so they can check it against everything else you take.
  • Do not stop a prescribed medicine on your own.
  • Check with your pharmacist or doctor before changing any medicine or supplement, especially if you take several or have an ongoing health condition.

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

K2/Spice Does Interact With Other Medications

K2/Spice has 208 moderate known drug interactions in our database — Nylidrin isn’t one of them. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against K2/Spice

Covers the 2,830 medications we’ve checked against K2/Spice. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Nylidrin

Take other supplements too? 20 supplements have a documented interaction with Nylidrin, each explained on its page.

By severity: 2 major, 9 moderate and 9 minor.

The Most Serious There Right Now:

Open the Nylidrin interaction pageEvery supplement checked against Nylidrin, ranked by severity
Supplement

About K2/Spice

K2/Spice is NOT a herbal supplement — it is plant material sprayed with man-made synthetic cannabinoid chemicals. It is dangerous, unpredictable, and has caused seizures, heart problems, psychosis, and deaths, so it should not be used.

Full K2/Spice guide: uses, dosage, safety and every interaction
Safety at a Glance

How K2/Spice Is Rated

  • K2/Spice Overall

    Avoid

    These products are illegal, unregulated, and have caused serious harm and death.

  • Pregnancy

    Avoid

    Never use during pregnancy; it can seriously harm both mother and baby.

  • Breastfeeding

    Avoid

    Avoid while breastfeeding; chemicals can pass to the infant and cause harm.

More to Explore

More Pairs and Interactions to Check

Keep Checking

Other Drugs & K2/Spice

Browse every other medication we’ve checked against K2/Spice — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
208Moderate
0Minor
2,621No known interaction
Moderate

Moderate: 208 interactions

Showing 60 of 208 moderate interactions — see all 208 on the K2/Spice page.

No Interaction 2,621 drugs checked — show the list

We also checked K2/Spice against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 2,621 medications checked with no known interaction, the most looked-up first — see the full K2/Spice list.

How Much People Look This Up

Where K2/Spice and Nylidrin Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement K2/Spice
Top half

#535 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Nylidrin
Steady interest

#2,315 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking K2/Spice and Nylidrin Together: Common Questions

Can you take K2/Spice with Nylidrin?
We do not list a known interaction between K2/Spice and Nylidrin, but that is not a reason to take K2/Spice: our pharmacy team rates it best avoided, whatever else you take. These products are illegal, unregulated, and have caused serious harm and death. Talk with your pharmacist or doctor before taking it, and do not stop or change Nylidrin on your own.
Can you take K2/Spice with Arlidin?
Arlidin is a brand name of nylidrin, so the answer is the same as for nylidrin. We do not list a known interaction between K2/Spice and Nylidrin, but that is not a reason to take K2/Spice: our pharmacy team rates it best avoided, whatever else you take. Everything on this page applies to Arlidin too.
How was the K2/Spice and Nylidrin combination checked?
Interactions in our licensed database are recorded against drug classes. Nylidrin is filed under 2 classifications, and K2/Spice has documented interactions with 2 drug classes — none of Nylidrin's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does K2/Spice interact with any other medications?
Yes. K2/Spice has 208 documented drug interactions in our database — Nylidrin is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Nylidrin interact with any supplements?
Yes. Nylidrin has documented interactions with 20 supplements in our database — K2/Spice is not one of them. The Nylidrin interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Evidence & Sources

References Cited on This Page

The 13 references the cards above cite, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

Show the 13 references
  1. 98843. Andonian DO, Seaman SR, Josephson EB. Profound hypotension and bradycardia in the setting of synthetic cannabinoid intoxication - a case series. Am J Emerg Med 2017;35(6):940.e5-940.e6. PubMed
  2. 98844. McIlroy G, Ford L, Khan JM. Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report. BMC Pharmacol Toxicol 2016;17:2. PubMed
  3. 98846. Clark BC, Georgekutty J, Berul CI. Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr 2015;167(3):757-61.e1. PubMed
  4. 98847. Davidson C, Opacka-Juffry J, Arevalo-Martin A, Garcia-Ovejero D, Molina-Holgado E, Molina-Holgado F. Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events. Adv Pharmacol 2017;80:135-68. PubMed
  5. 98848. Durand D, Delgado LL, de la Parra-Pellot DM, Nichols-Vinueza D. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: a case report. Clin Schizophr Relat Psychoses 2015;8(4):205-8. DOI
  6. 98849. Freeman MJ, Rose DZ, Myers MA, Gooch CL, Bozeman AC, Burgin WS. Ischemic stroke after use of the synthetic marijuana "spice". Neurology 2013;81(24):2090-3. PubMed
  7. 99616. Lamy FR, Daniulaityte R, Nahhas RW, et al. Increases in synthetic cannabinoids-related harms: results from a longitudinal web-based content analysis. Int J Drug Policy. 2017;44:121-9. PubMed
  8. 99617. Law R, Schier J, Martin C, Chang A, Wolkin A; Centers for Disease Control (CDC). Notes from the field: increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015. MMWR Morb Mortal Wkly Rep 2015;64(22
  9. 99618. Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12-41. PubMed
  10. 99619. Monte AA, Calello DP, Gerona RR, et al. Characteristics and treatment of patients with clinical illness due to synthetic cannabinoid inhalation reported by medical toxicologists: a ToxIC database study. J Med Toxicol 2017;13(2):146-52. PubMed
  11. 99621. Schwartz MD, Trecki J, Edison LA, Steck AR, Arnold JK, Gerona RR. A common source outbreak of severe delirium associated with exposure to the novel synthetic cannabinoid ADB-PINACA. J Emerg Med 2015;48(5):573-80. PubMed
  12. 99624. Tait RJ, Caldicott D, Mountain D, Hill SL, Lenton S. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 2016;54(1):1-13. PubMed
  13. 103080. Kourouni I, Mourad B, Khouli H, Shapiro JM, Mathew JP. Critical Illness Secondary to Synthetic Cannabinoid Ingestion. JAMA Netw Open. 2020;3(7):e208516. PubMed

All 40 references behind our K2/Spice records are listed in the K2/Spice guide.

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is reviewed by the HelloPharmacist Editorial Team. See our data sources and editorial standards.

Where Does Our Data Come From?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 105,612 references behind our interaction content, 67,053 of them resolved to verified PubMed/DOI sources. See the references behind this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified November 15, 2026. The K2/Spice and Nylidrin records this page draws on were last updated October 20, 2026.
Data structure & sourcing designed and verified by .
Rating Key

What Our Interaction Ratings Mean

No interaction is on record for this pair. The other supplements and medicines on this page carry a severity rating: how serious an interaction between them is.

See what each severity means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Still Have a Question About K2/Spice and Nylidrin?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.